Background: Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients
causes both ''direct''and ''indirect''effects including allograft rejection, decreased graft and …

Viruses are among the most common causes of opportunistic infection after transplantation
and the most important. The risk for viral infection is a function of the specific virus …

The precise impact of valganciclovir as preventive therapy for cytomegalovirus (CMV) in
solid organ transplant (SOT) recipients is not fully defined. Data from studies using …

Neutropenic episodes in kidney transplant patients are poorly characterized. In this
retrospective study, neutropenia was experienced by 112/395 patients (28%) during the first …

Infections are the leading cause of hospitalization in transplant recipients. The increased risk
of new onset diabetes after transplantation, cardiovascular disease, post-transplant …

Lymphoma is a heterogeneous malignancy of the lymphatic system characterized by
proliferation of lymphoid cells or their precursors. Non-Hodgkin lymphoma (NHL) is …

Background. Cytomegalovirus (CMV) infection is associated with reduced graft and patient
survival among kidney recipients. The highest risk of CMV infection occurs in CMV-naïve …

Background. Posttransplant neutropenia (PTN) is relatively common after kidney
transplantation, and may result in a reduction of immunosuppression, which may precipitate …

The myelosuppressive and mucosal-damaging consequences of cancer and cancer
therapies place patients at high risk for developing infectious complications. Bacterial …

Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …